Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Sander

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Microcirculation (New York, N.Y. : 1994)|February 29, 2020
Capillary microscopy in Europeans with idiopathic Moyamoya angiopathyOliver Sander, Jan Claudius Schwitalla, Marius Ringelstein, et al.
Plos Computational Biology|April 3, 2007
Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usageOliver Sander, Tobias Sing, Ingolf Sommer, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 25, 2021
A framework to guide dose & regimen strategy for clinical drug developmentOliver Sander, Baldur Magnusson, Inga Ludwig, et al.
Journal of Personalized Medicine|September 28, 2023
High Frequency of Osteophytes Detected by High-Resolution Ultrasound at the Finger Joints of Asymptomatic Factory WorkersMario Giulini, Ralph Brinks, Stefan Vordenbäumen, et al.
Plos One|February 24, 2026
Association of G-Protein-Coupled Receptors autoantibodies with vasoregulation in Post-COVIDFelix S Seibert, Melisa Kurucay, Lea Wiemers, et al.
Clinical and Experimental Rheumatology|March 24, 2015
Validation and evaluation of the German version of the Systemic Lupus Activity Questionnaire (SLAQ)Gamal Chehab, Jutta Richter, Oliver Sander, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 5, 2021
Estimands-What they are and why they are important for pharmacometriciansMouna Akacha, Christian Bartels, Björn Bornkamp, et al.
The Journal of Rheumatology|April 3, 2003
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritisRolf Rau, Oliver Sander, Piet van Riel, et al.
Clinical Pharmacology and Therapeutics|January 14, 2018
Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic UseSatyaprakash Nayak, Oliver Sander, Nidal Al-Huniti, et al.
Digital Biomarkers|February 26, 2020
Observational Study of a Wearable Sensor and Smartphone Application Supporting Unsupervised Exercises to Assess Pain and StiffnessCaroline G M Perraudin, Vittorio P Illiano, Francesc Calvo, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Microcirculation (New York, N.Y. : 1994)|February 29, 2020
Capillary microscopy in Europeans with idiopathic Moyamoya angiopathyOliver Sander, Jan Claudius Schwitalla, Marius Ringelstein, et al.
Plos Computational Biology|April 3, 2007
Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usageOliver Sander, Tobias Sing, Ingolf Sommer, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 25, 2021
A framework to guide dose & regimen strategy for clinical drug developmentOliver Sander, Baldur Magnusson, Inga Ludwig, et al.
Journal of Personalized Medicine|September 28, 2023
High Frequency of Osteophytes Detected by High-Resolution Ultrasound at the Finger Joints of Asymptomatic Factory WorkersMario Giulini, Ralph Brinks, Stefan Vordenbäumen, et al.
Plos One|February 24, 2026
Association of G-Protein-Coupled Receptors autoantibodies with vasoregulation in Post-COVIDFelix S Seibert, Melisa Kurucay, Lea Wiemers, et al.
Clinical and Experimental Rheumatology|March 24, 2015
Validation and evaluation of the German version of the Systemic Lupus Activity Questionnaire (SLAQ)Gamal Chehab, Jutta Richter, Oliver Sander, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 5, 2021
Estimands-What they are and why they are important for pharmacometriciansMouna Akacha, Christian Bartels, Björn Bornkamp, et al.
The Journal of Rheumatology|April 3, 2003
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritisRolf Rau, Oliver Sander, Piet van Riel, et al.
Clinical Pharmacology and Therapeutics|January 14, 2018
Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic UseSatyaprakash Nayak, Oliver Sander, Nidal Al-Huniti, et al.
Digital Biomarkers|February 26, 2020
Observational Study of a Wearable Sensor and Smartphone Application Supporting Unsupervised Exercises to Assess Pain and StiffnessCaroline G M Perraudin, Vittorio P Illiano, Francesc Calvo, et al.
Pageof 7